Abstract
Background: Two large-scale genome-wide association studies have identified rs610932 and rs670139 polymorphisms within the MS4A gene cluster as being significantly associated with susceptibility to Alzheimer’s disease (AD) in those with European ancestry. A number of studies have focused on the association between MS4A gene variants and AD in Caucasian and East Asian populations. However, the results remain inconsistent owing to the small sample size in each study.
Objective: We performed a meta-analysis to explore whether rs610932 and rs670139 polymorphisms are associated with susceptibility to AD. Method: 19 studies with 34,119 cases and 56,956 controls concerning rs610932 and 18 studies with 33,622 cases and 55,322 controls concerning rs670139 were included in this meta-analysis by searching the PubMed, MEDLINE, and AlzGene databases. Results: Our results showed significant associations between rs610932 and rs670139 polymorphisms and AD in the pooled population using an additive model. In subgroup analysis, we also identified a significant association of rs610932 in the Asian population under additive [odds ratio=0.82, 95% confidence interval 0.69-0.99, p=0.03] and dominant models (odds ratio=0.82, 95% confidence interval 0.72-0.95, p=0.006), but not under a recessive model. However, no association was found between rs670139 and AD patients using all three of these models in the Asian population. Conclusion: Our results suggest that the rs610932 polymorphism contributes to AD susceptibility in Caucasian and Asian populations. To our knowledge, this is the largest meta-analysis to investigate the association between MS4A gene polymorphisms and AD in Asian and European populations.Keywords: Alzheimer's disease, meta-analysis, MS4A gene cluster, rs610932, rs670139.
Current Alzheimer Research
Title:Association of rs610932 and rs670139 Polymorphisms in the MS4A Gene Cluster with Alzheimer’s Disease: An Updated Meta-analysis
Volume: 14 Issue: 3
Author(s): Ruixia Zhu, Xu Liu and Zhiyi He
Affiliation:
Keywords: Alzheimer's disease, meta-analysis, MS4A gene cluster, rs610932, rs670139.
Abstract: Background: Two large-scale genome-wide association studies have identified rs610932 and rs670139 polymorphisms within the MS4A gene cluster as being significantly associated with susceptibility to Alzheimer’s disease (AD) in those with European ancestry. A number of studies have focused on the association between MS4A gene variants and AD in Caucasian and East Asian populations. However, the results remain inconsistent owing to the small sample size in each study.
Objective: We performed a meta-analysis to explore whether rs610932 and rs670139 polymorphisms are associated with susceptibility to AD. Method: 19 studies with 34,119 cases and 56,956 controls concerning rs610932 and 18 studies with 33,622 cases and 55,322 controls concerning rs670139 were included in this meta-analysis by searching the PubMed, MEDLINE, and AlzGene databases. Results: Our results showed significant associations between rs610932 and rs670139 polymorphisms and AD in the pooled population using an additive model. In subgroup analysis, we also identified a significant association of rs610932 in the Asian population under additive [odds ratio=0.82, 95% confidence interval 0.69-0.99, p=0.03] and dominant models (odds ratio=0.82, 95% confidence interval 0.72-0.95, p=0.006), but not under a recessive model. However, no association was found between rs670139 and AD patients using all three of these models in the Asian population. Conclusion: Our results suggest that the rs610932 polymorphism contributes to AD susceptibility in Caucasian and Asian populations. To our knowledge, this is the largest meta-analysis to investigate the association between MS4A gene polymorphisms and AD in Asian and European populations.Export Options
About this article
Cite this article as:
Zhu Ruixia, Liu Xu and He Zhiyi, Association of rs610932 and rs670139 Polymorphisms in the MS4A Gene Cluster with Alzheimer’s Disease: An Updated Meta-analysis, Current Alzheimer Research 2017; 14 (3) . https://dx.doi.org/10.2174/1567205013666161108110828
DOI https://dx.doi.org/10.2174/1567205013666161108110828 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Urokinase Receptor in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Approaches to a Multitargeting Drug Development: First Profiled 3- Ethoxycarbonyl-1-aza-9-oxafluorenes Representing a Perspective Compound Class Targeting Alzheimer Disease Relevant Kinases CDK1, CDK5 and GSK-3β
Medicinal Chemistry Something Old, Something New and Something Used in Alzheimer's; the Idea of Pore, Ethanol and the Use of Oocytes to Understand the Disease
Current Chemical Biology Geniposide Attenuates Mitochondrial Dysfunction and Memory Deficits in APP/PS1 Transgenic Mice
Current Alzheimer Research Visual Event-Related Potentials in Mild Cognitive Impairment and Alzheimer’s Disease: A Literature Review
Current Alzheimer Research Oxidative Stress in the Pathogenesis of Alzheimer’s Disease and Cerebrovascular Disease with Therapeutic Implications
CNS & Neurological Disorders - Drug Targets Tackling the Elusive Challenges Relevant to Conquering the 100-Plus Year Old Problem of Alzheimer’s Disease
Current Alzheimer Research Denervation of the Olfactory Bulb Leads to Decreased Aβ Plaque Load in a Transgenic Mouse Model of Alzheimer’ s Disease
Current Alzheimer Research Easy Screening for Mild Alzheimer's Disease and Mild Cognitive Impairment from Elderly Speech
Current Alzheimer Research Mitochondrial Proteases as Emerging Pharmacological Targets
Current Pharmaceutical Design Commentary Research Highlights: Untangling Alzheimer Disease Pathology
CNS & Neurological Disorders - Drug Targets HIV-1-Associated Dementia During HAART Therapy
Recent Patents on CNS Drug Discovery (Discontinued) Environment, Physical Activity, and Neurogenesis: Implications for Prevention and Treatment of Alzhemiers Disease
Current Alzheimer Research Advanced Glycation End Products, Oxidative Stress and Metalloproteinases are altered in the Cerebral Microvasculature during Aging
Current Neurovascular Research Possible Role of Vascular Risk Factors in Alzheimer's Disease and Vascular Dementia
Current Pharmaceutical Design Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems
Current Drug Targets Advantages of Nanotechnology- Based Chinese Herb Drugs on Biological Activities
Current Drug Metabolism Strain Specificity and Drug Resistance in Anti-Prion Therapy
Current Topics in Medicinal Chemistry Reviewing the Role of Resveratrol as a Natural Modulator of Microglial Activities
Current Pharmaceutical Design Physical Activity as a Moderator of Alzheimer Pathology: A Systematic Review of Observational Studies
Current Alzheimer Research